BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $207,000 | -16.9% | 3,222 | +0.2% | 0.01% | -30.0% |
| Q1 2022 | $249,000 | -14.7% | 3,216 | -5.2% | 0.01% | -9.1% |
| Q4 2021 | $292,000 | +12.3% | 3,393 | +5.0% | 0.01% | -8.3% |
| Q3 2021 | $260,000 | +1.2% | 3,230 | +1.1% | 0.01% | 0.0% |
| Q2 2021 | $257,000 | -4.8% | 3,194 | -0.4% | 0.01% | -7.7% |
| Q1 2021 | $270,000 | -74.4% | 3,207 | -75.6% | 0.01% | -75.9% |
| Q4 2020 | $1,055,000 | +6.9% | 13,154 | +7.1% | 0.05% | -22.9% |
| Q3 2020 | $987,000 | -22.6% | 12,279 | -17.2% | 0.07% | -34.6% |
| Q2 2020 | $1,276,000 | -28.5% | 14,825 | -32.6% | 0.11% | -50.5% |
| Q1 2020 | $1,785,000 | -49.8% | 21,990 | -47.1% | 0.22% | +13.7% |
| Q4 2019 | $3,557,000 | +89.6% | 41,555 | +93.7% | 0.19% | -15.9% |
| Q3 2019 | $1,876,000 | +27.8% | 21,450 | +19.7% | 0.23% | +41.2% |
| Q2 2019 | $1,468,000 | -3.7% | 17,924 | -4.4% | 0.16% | -5.9% |
| Q1 2019 | $1,525,000 | +2.1% | 18,756 | -17.3% | 0.17% | -6.6% |
| Q4 2018 | $1,493,000 | -58.0% | 22,685 | -50.8% | 0.18% | -53.9% |
| Q3 2018 | $3,554,000 | +3.8% | 46,098 | -0.5% | 0.40% | -6.0% |
| Q2 2018 | $3,423,000 | +11.3% | 46,350 | -2.0% | 0.42% | +0.5% |
| Q1 2018 | $3,076,000 | -0.9% | 47,279 | -1.6% | 0.42% | +0.2% |
| Q4 2017 | $3,105,000 | -20.6% | 48,040 | -22.9% | 0.42% | -18.1% |
| Q3 2017 | $3,912,000 | +3.8% | 62,341 | +0.1% | 0.51% | +4.9% |
| Q2 2017 | $3,770,000 | +671.0% | 62,263 | +559.9% | 0.48% | +722.0% |
| Q1 2017 | $489,000 | +16.7% | 9,435 | -0.2% | 0.06% | +28.3% |
| Q4 2016 | $419,000 | -8.7% | 9,458 | -2.0% | 0.05% | +9.5% |
| Q3 2016 | $459,000 | +3.6% | 9,652 | -1.7% | 0.04% | +5.0% |
| Q2 2016 | $443,000 | +4.0% | 9,816 | -5.2% | 0.04% | +11.1% |
| Q1 2016 | $426,000 | +34.0% | 10,358 | +24.4% | 0.04% | +56.5% |
| Q4 2015 | $318,000 | -41.8% | 8,325 | -50.0% | 0.02% | +15.0% |
| Q3 2015 | $546,000 | -31.8% | 16,650 | +45.4% | 0.02% | -63.6% |
| Q2 2015 | $800,000 | +7.0% | 11,448 | +4.8% | 0.06% | +5.8% |
| Q1 2015 | $748,000 | -77.8% | 10,928 | -78.7% | 0.05% | -59.7% |
| Q3 2013 | $3,375,000 | -4.7% | 51,383 | +0.5% | 0.13% | -11.0% |
| Q2 2013 | $3,540,000 | – | 51,118 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |